Hua Y, Gao D, Wang K, Ding X, Xu W, Li Y
Thorac Cancer. 2023; 14(31):3133-3139.
PMID: 37718465
PMC: 10626225.
DOI: 10.1111/1759-7714.15106.
Liao G, Khan M, Zhao Z, Arooj S, Yan M, Li X
Front Oncol. 2021; 11:593449.
PMID: 33842309
PMC: 8027305.
DOI: 10.3389/fonc.2021.593449.
Banks P, Lasocki A, Lau P, Sandhu S, McArthur G, Shackleton M
Health Sci Rep. 2019; 2(3):e115.
PMID: 30937392
PMC: 6427059.
DOI: 10.1002/hsr2.115.
Zhuang H, Shi S, Yuan Z, Chang J
Mol Cancer. 2019; 18(1):21.
PMID: 30732625
PMC: 6367784.
DOI: 10.1186/s12943-019-0950-1.
Delishaj D, Ursino S, Pasqualetti F, Cristaudo A, Cosottini M, Fabrini M
J Clin Med Res. 2017; 9(4):273-280.
PMID: 28270886
PMC: 5330769.
DOI: 10.14740/jocmr2936e.
The Effectiveness of Bevacizumab in Radionecrosis After Radiosurgery of a Single Brain Metastasis.
Delishaj D, Ursino S, Pasqualetti F, Pesaresi I, Desideri I, Cosottini M
Rare Tumors. 2016; 7(4):6018.
PMID: 26788278
PMC: 4703924.
DOI: 10.4081/rt.2015.6018.
Changes in protein level in the cerebrospinal fluid of a patient with cerebral radiation necrosis treated with bevacizumab.
Yano H, Nakayama N, Morimitsu K, Futamura M, Ohe N, Miwa K
Clin Med Insights Oncol. 2015; 8:153-7.
PMID: 25574147
PMC: 4263439.
DOI: 10.4137/CMO.S19823.
A new strategy of CyberKnife treatment system based radiosurgery followed by early use of adjuvant bevacizumab treatment for brain metastasis with extensive cerebral edema.
Wang Y, Wang E, Pan L, Dai J, Zhang N, Wang X
J Neurooncol. 2014; 119(2):369-76.
PMID: 24879376
DOI: 10.1007/s11060-014-1488-0.
An analysis of radiation necrosis of the central nervous system treated with bevacizumab.
Tye K, Engelhard H, Slavin K, Nicholas M, Chmura S, Kwok Y
J Neurooncol. 2014; 117(2):321-7.
PMID: 24504500
DOI: 10.1007/s11060-014-1391-8.
Bevacizumab treatment in malignant meningioma with additional radiation necrosis. An MRI diffusion and perfusion case study.
Bostrom J, Seifert M, Greschus S, Schafer N, Glas M, Lammering G
Strahlenther Onkol. 2014; 190(4):416-21.
PMID: 24429478
DOI: 10.1007/s00066-013-0505-0.
Results of a questionnaire regarding practice patterns for the diagnosis and treatment of intracranial radiation necrosis after SRS.
Stockham A, Ahluwalia M, Reddy C, Suh J, Kumar A, Vogelbaum M
J Neurooncol. 2013; 115(3):469-75.
PMID: 24045970
DOI: 10.1007/s11060-013-1248-6.
Bevacizumab for refractory adverse radiation effects after stereotactic radiosurgery.
Deibert C, Ahluwalia M, Sheehan J, Link M, Hasegawa T, Yomo S
J Neurooncol. 2013; 115(2):217-23.
PMID: 23929592
DOI: 10.1007/s11060-013-1214-3.
Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients.
Wang Y, Pan L, Sheng X, Mao Y, Yao Y, Wang E
Eur J Med Res. 2012; 17:25.
PMID: 22913802
PMC: 3493338.
DOI: 10.1186/2047-783X-17-25.
Antiangiogenic therapy for glioblastoma.
Gerstner E, Batchelor T
Cancer J. 2012; 18(1):45-50.
PMID: 22290257
PMC: 3269655.
DOI: 10.1097/PPO.0b013e3182431c6f.
